Prescription drug improves symptoms of autism by targeting brain's chemical messengers
Researchers find that bumetanide reduces symptoms of autism by decreasing GABA to glutamate ratio, improving brain function and social communication. The treatment has been shown to be safe and effective in reducing symptoms in children as young as three years old.